Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Net Margin: 2009-2024

Historic Net Margin for Ani Pharmaceuticals (ANIP) over the last 16 years, with Dec 2024 value amounting to -3.28%.

  • Ani Pharmaceuticals' Net Margin rose 2810.00% to 11.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.72%, marking a year-over-year increase of 629.00%. This contributed to the annual value of -3.28% for FY2024, which is 680.00% down from last year.
  • As of FY2024, Ani Pharmaceuticals' Net Margin stood at -3.28%, which was down 193.06% from 3.52% recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' Net Margin peaked at 3.52% during FY2023, and registered a low of -19.80% during FY2021.
  • Over the past 3 years, Ani Pharmaceuticals' median Net Margin value was -3.28% (recorded in 2024), while the average stood at -5.14%.
  • In the last 5 years, Ani Pharmaceuticals' Net Margin slumped by 1,377bps in 2020 and then skyrocketed by 1,918bps in 2023.
  • Ani Pharmaceuticals' Net Margin (Yearly) stood at -10.82% in 2020, then plummeted by 898bps to -19.80% in 2021, then soared by 415bps to -15.65% in 2022, then skyrocketed by 1,918bps to 3.52% in 2023, then crashed by 680bps to -3.28% in 2024.